Correlation Between West Pharmaceutical and Sight Sciences

Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and Sight Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and Sight Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between West Pharmaceutical Services and Sight Sciences, you can compare the effects of market volatilities on West Pharmaceutical and Sight Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of Sight Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and Sight Sciences.

Diversification Opportunities for West Pharmaceutical and Sight Sciences

-0.6

Correlation Coefficient

West Pharmaceutical  Sight Sciences

Excellent diversification

The 3 months correlation between West and Sight is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and Sight Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sight Sciences and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with Sight Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sight Sciences has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and Sight Sciences go up and down completely randomly.

Pair Corralation between West Pharmaceutical and Sight Sciences

Considering the 90-day investment horizon West Pharmaceutical Services is expected to generate 0.71 times more return on investment than Sight Sciences. However, West Pharmaceutical Services is 1.42 times less risky than Sight Sciences. It trades about 0.05 of its potential returns per unit of risk. Sight Sciences is currently generating about -0.18 per unit of risk. If you would invest  30,011  in West Pharmaceutical Services on September 5, 2024 and sell it today you would earn a total of  2,178  from holding West Pharmaceutical Services or generate 7.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

West Pharmaceutical Services  vs.  Sight Sciences

West Pharmaceutical

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, West Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Sight Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with West Pharmaceutical and Sight Sciences

The main advantage of trading using opposite West Pharmaceutical and Sight Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, Sight Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sight Sciences will offset losses from the drop in Sight Sciences' long position.

The idea behind West Pharmaceutical Services and Sight Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.